InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: chmcnfunds post# 2153

Monday, 02/04/2013 8:49:05 AM

Monday, February 04, 2013 8:49:05 AM

Post# of 3329
JMP Securities' Jason Butler jumps to Keryx's (KERX -0.7%) defense today after the stock...
Monday, February 4, 8:44 AM ET
JMP Securities' Jason Butler jumps to Keryx's (KERX -0.7%) defense today after the stock plummeted 22% on Friday following a report from research firm IPD Analytics that questioned whether the FDA will grant the company New Chemical Entity status for its Zerenex treatment for patients undergoing dialysis. IDP reckons that the active ingredient in Zerenex may be too similar to an existing chemical called Ferriseltz, although Butler begs to differ.
________________________________________________________

http://seekingalpha.com/currents/post/801111?source=email_rt_mc_readmore

KERX
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.